Comanche Biopharma Drug Receives FDA Fast Track Designation ...Middle East

CONCORD, Mass., Aug. 23, 2023 /PRNewswire/ -- Comanche Biopharma Corp. today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the investigation of Comanche's asset CBP-4888 as a novel siRNA therapy for preeclampsia. Preeclampsia...

Hence then, the article about comanche biopharma drug receives fda fast track designation was published today ( Wednesday 23/08/2023 - 07:13 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Comanche Biopharma Drug Receives FDA Fast Track Designation )

Also on site :

• Travis County deputy arrested on official oppression charge
• 10 Shows Like 'Your Friends and Neighbors' You Should Watch Next
• Why have the US and Israel bombed more than 75 Iranian police facilities?